RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity [ChIP-Rx]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 24 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 24 samples: 12 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE313845_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1381662 and SRA study SRP655437. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 12 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9376418 Input_R4KO_2A_Rep1 Input_R4KO_2A
- GSM9376419 Input_R4KO_2A_Rep2 Input_R4KO_2A
- GSM9376420 Input_R4KO_Vector_Rep1 Input_R4KO_Vector
- GSM9376421 Input_R4KO_Vector_Rep2 Input_R4KO_Vector
- GSM9376422 Input_R4KO_wt_Rep1 Input_R4KO_wt
- GSM9376423 Input_R4KO_wt_Rep2 Input_R4KO_wt
- GSM9376424 Input_siControl_Rep1 Input_siControl
- GSM9376425 Input_siControl_Rep2 Input_siControl
- GSM9376426 Input_siREXO4_1_Rep1 Input_siREXO4_1
- GSM9376427 Input_siREXO4_1_Rep2 Input_siREXO4_1
- GSM9376428 Input_siREXO4_1_RNaseH1_Rep1 Input_siREXO4_1_RNaseH1
- GSM9376429 Input_siREXO4_1_RNaseH1_Rep2 Input_siREXO4_1_RNaseH1
- GSM9376430 IP_PolII_R4KO_2A_Rep1 IP_PolII_R4KO_2A
- GSM9376431 IP_PolII_R4KO_2A_Rep2 IP_PolII_R4KO_2A
- GSM9376432 IP_PolII_R4KO_Vector_Rep1 IP_PolII_R4KO_Vector
- GSM9376433 IP_PolII_R4KO_Vector_Rep2 IP_PolII_R4KO_Vector
- GSM9376434 IP_PolII_R4KO_wt_Rep1 IP_PolII_R4KO_wt
- GSM9376435 IP_PolII_R4KO_wt_Rep2 IP_PolII_R4KO_wt
- GSM9376436 IP_PolII_siControl_Rep1 IP_PolII_siControl
- GSM9376437 IP_PolII_siControl_Rep2 IP_PolII_siControl
- GSM9376438 IP_PolII_siREXO4_1_Rep1 IP_PolII_siREXO4_1
- GSM9376439 IP_PolII_siREXO4_1_Rep2 IP_PolII_siREXO4_1
- GSM9376440 IP_PolII_siREXO4_1_RNaseH1_Rep1 IP_PolII_siREXO4_1_RNas…
- GSM9376441 IP_PolII_siREXO4_1_RNaseH1_Rep2 IP_PolII_siREXO4_1_RNas…
- GSE313850 RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity [CUT&Tag-seq] 44 samples shares m6a-marked, rexo4, exonuclease, suppresses, anti-tumor, resolves, immunity, r-loops
- GSE313848 RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity [MRC-seq] 16 samples shares m6a-marked, rexo4, exonuclease, suppresses, anti-tumor, resolves, immunity, r-loops
- GSE306391 G-Quadruplex DNA suppresses Transcription during DNA Replication [CUT&Tag] 264 samples shares suppresses
- GSE299672 PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers [ChIP-seq] 132 samples shares suppresses
- GSE245925 A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo (ChIP-Seq) 63 samples shares suppresses
- GSE215023 Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF 58 samples shares suppresses
- GSE307716 Small interfering RNA-mediated silencing of mutant NPM1 suppresses acute myeloid leukemia via reversing KAT7 and p300-mediated histone acetylation [CUT&Tag] 52 samples shares suppresses
- GSE269555 Targeting the oncohistone-ASCL1 axis disrupts plasticity and suppresses pediatric gliomas [CUT&RUN] 39 samples shares suppresses
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.